Industry News
Dopamine may be a safe anti-angiogenic drug in cancer treatment
Jan 09, 2015
A new study led by scientists at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Read More
Women with small, HER2+ breast tumors treated with combined therapy have reduced chance of recurrence
Jan 09, 2015
In a phase 2 clinical trial, women with small (stage 1), HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly... Read More
Graphene 'flying carpet' technique delivers one-two punch of anticancer drugs
Jan 09, 2015
An international team of researchers has developed a drug delivery technique that utilizes graphene strips as "flying carpets" to deliver two anticancer drugs sequentially to cancer cells, with each... Read More
Key cancer-promoting gene uncovered
Jan 09, 2015
One of the mysteries in cancer biology is how one protein, TGF-beta, can both stop cancer from forming and encourage its aggressive growth. Read More
Vanderbilt-led team studies blood test for prostate cancer
Jan 08, 2015
Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting "cell-free" tumor DNA in the bloodstream. Read More
More than a third of people with abnormal results drop out of bowel cancer screening
Jan 08, 2015
Almost 40 per cent of people who have abnormal results from bowel cancer screening tests and are referred for further investigation ignore their next screening invitation two years later, according... Read More
HPV vaccination not associated with increased risk of multiple sclerosis
Jan 08, 2015
Although some reports have suggested a link between human papillomavirus (HPV) vaccination and development of multiple sclerosis or other demyelinating diseases (a group of central nervous system... Read More
cCam Biotherapeutics receives FDA approval to initiate Phase 1 trial for CM-24, a novel immune checkpoint inhibitor for cancer immunotherapy
Jan 08, 2015
cCAM Biotherapeutics, a biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies, has announced that it has received approval form the US Food and Drug... Read More
Barts Health joins pioneering DNA study, UK
Jan 08, 2015
Barts Health NHS Trust is among six London hospital trusts who have come together to launch a pioneering study using patient genetics (DNA) to create personalised treatment for people with cancer... Read More
HPV vaccination not associated with increased risk of multiple sclerosis
Jan 08, 2015
Although some reports have suggested a link between human papillomavirus (HPV) vaccination and development of multiple sclerosis or other demyelinating diseases (a group of central nervous system... Read More
Previous Page Next Page